Trial record 1 of 1 for:    NCT02155647
Previous Study | Return to List | Next Study

Avelumab in Subjects With Merkel Cell Carcinoma (JAVELIN Merkel 200)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02155647
Recruitment Status : Active, not recruiting
First Posted : June 4, 2014
Last Update Posted : September 27, 2018
Information provided by (Responsible Party):
EMD Serono

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Estimated Primary Completion Date : April 30, 2019
  Estimated Study Completion Date : April 30, 2023
Publications of Results:
Publications automatically indexed to this study by Identifier (NCT Number):